| Vol. 5.40 – 29 October, 2021 |
| |
|
|
| Scientists investigated the expression and function of annexin A11 in human cholangiocytes and a potential role of IgG1/IgG4-mediated autoreactivity against annexin A11 in the pathogenesis of IgG4-related cholangitis. [Journal of Hepatology] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors suggested that infiltrative monocytes promoted fibrogenesis in nonalcoholic fatty liver disease via adenosine deaminase 2-mediated autocrine/paracrine signaling culminating in enhanced PDGF-B production. [Cell Reports] |
|
|
|
| Researchers used a chemical proteomics strategy that had identified STAT3, a transcription factor considered to be undruggable, as a direct functional protein target of rapamycin. They showed that rapamycin treatment in cell culture significantly inhibited c-Myc-regulated gene expression. [Cell Chemical Biology] |
|
|
|
| Scientists suggested that circUBE2J2 may have acted as a competing endogenous RNA to regulate KLF7 expression through sponging miR-370-5P, and played regulatory functions in hepatocellular carcinoma. [Cell Death & Disease] |
|
|
|
| To address the effect of Arid1a deficiency on chromatin organization, investigators generated chromatin interaction matrices, and exploited the conformation changes upon Arid1a depletion in hepatocytes. [Cell Death & Disease] |
|
|
|
| Researchers examined phosphorylated nuclear factor erythroid 2–related factor 2 (P-NRF2) expression in surgically resected primary hepatocellular carcinoma and investigated the association of P-NRF2 expression with clinicopathological features and patient outcome. [Hepatology Communications] |
|
|
|
| To obtain a cellular resolution of pathogenesis, 82,168 single-cell transcriptomes across different nonalcoholic fatty liver disease stages were profiled, identifying hepatocytes and 12 other non-parenchymal cell types. [iScience] |
|
|
|
| The authors reported that the lymphokine LIGHT/TNFSF14 was upregulated in the murine NAFLD livers and in hepatocytes treated with free fatty acids [Cell Death Discovery] |
|
|
|
| Researchers determined the clinical value, biological functions, and potential mechanisms of RNA-binding motif protein 15 (RBM15) in hepatocellular carcinoma. [Cell Death Discovery] |
|
|
|
| The autophagy attenuation exerted by chloroquine together with the reduction of the expression of the proliferation marker in hepatic stellate cells could lessen the acute liver damage, potentially opening the way to novel therapeutic approaches for hepatic fibrosis. [Journal of Gastroenterology and Hepatology] |
|
|
|
| A series of fluorinated imidazole phenanthroline derivatives were synthesized and investigated as potential inhibitors against the growth of liver cancer cells. [Chemmedchem] |
|
|
|
| Scientists investigated the apoptotic capacity of GenX in human liver cells. When representative human-derived liver cells (HepG2 cells) were treated with GenX for 12 hours, cell viability was reduced, and apoptosis was greatly increased. [Heliyon] |
|
|
|
|
| The intensity of cirrhosis-associated immune dysfunction has important consequences on cirrhosis progression and correlates with the severity of liver insufficiency, bacterial translocation and organ failure. [Nature Reviews Gastroenterology & Hepatology] |
|
|
|
| Reports on the roles of hepatocellular carcinoma (HCC)-derived extracellular vesicles (EVs) in tumorigenesis, and clinical investigations using circulating EVs as a biomarker for HCC and their potential diagnostic are comprehensively summarized and discussed. [Cancer Medicine] |
|
|
|
| Investigators discuss the current state of non-alcoholic fatty liver disease metabolites, gut micro-environmental changes, and the further challenges in digital metabolomics profiling. [Clinica Chimica Acta] |
|
|
|
|
| Ubiquigent Limited announced the extension and expansion of its long-term collaboration with Bristol Myers Squibb, and will provide Bristol Myers Squibb with increased access to its deubiquitylase enzyme inhibitor drug discovery platform to provide further support to additional therapeutic areas. [Ubiquigent Limited (Lifescience Newswire, Inc.)] |
|
|
|
|
| November 10 – 11, 2021 Seoul, Korea & Online |
|
|
|
|
|
| Saint Louis University – St. Louis, Missouri, United States |
|
|
|
| Genome Institute of Singapore – Singapore, Singapore |
|
|
|
| Gordian Biotechnology – San Francisco, California, United States |
|
|
|
| National Institutes of Health – Bethesda, Maryland, United States |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
|